EUVIMEDEUVIMED entdecken
Validierungsstudie

Benzo[a]pyrene exacerbates atherosclerosis by upregulating SPP1 to promote macrophage inflammation and lipid dysregulation: An integrated network toxicology, RNA-seq, and experimental validation study

Runwen Li, Jieting Zheng, Yongjiang Tang, Aman Liu, Jiang Liu, Shanshan Cai

Vascular Pharmacology · 2026

DOI: 10.1016/j.vph.2026.107589 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Vascular Pharmacology, 2026. Verfasst von Runwen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Diseases, Panzhihua Central Hospital, Panzhihua 617000, China. Hauptthemen laut MEDLINE: Benzo(a)pyrene, Atherosclerosis, Macrophages, Lipid Metabolism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzo[a]pyrene (BaP), a pervasive environmental pollutant, has been implicated in cardiovascular injury, yet its mechanistic contribution to atherosclerosis remains unclear. Here, we combined network toxicology, RNA-seq profiling, molecular simulations, and cellular validation to elucidate BaP-driven vascular effects. Integration of BaP-associated targets with atherosclerosis gene sets identified SPP1 as a key hub. Transcriptomic analysis of aortas from BaP-treated ApoE-/- mice revealed differential expression enriched in inflammatory responses, cytokine signaling, xenobiotic metabolism, and lipid-handling pathways. STRING-based protein interaction networks and Reactome analysis further supported coordinated activation of innate immunity and metabolic dysfunction. Molecular docking and 100-ns MD simulations demonstrated stable, energetically favorable binding between BaP and SPP1. In THP-1 macrophages, BaP enhanced oxLDL-induced SPP1 expression, reduced cell viability, and promoted a foam-cell-like phenotype characterized by suppressed ABCA1 and increased CD36 and PLIN2. Silencing SPP1 partially rescued BaP-induced cytotoxicity and lipid dysregulation, confirming SPP1's functional involvement. Collectively, these findings indicate that BaP aggravates atherosclerosis through SPP1-mediated macrophage inflammation and impaired lipid metabolism, highlighting SPP1 as a potential mechanistic link and therapeutic target for pollution-exacerbated vascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzo(a)pyreneAtherosclerosisMacrophagesLipid MetabolismOsteopontinFoam CellsInflammationAortic DiseasesAortaAnimalsHumansTHP-1 CellsUp-RegulationMice, Knockout, ApoEDisease Models, AnimalMice, Inbred C57BLRNA-SeqSignal TransductionMiceMaleMolecular Docking SimulationInflammation MediatorsPlaque, AtheroscleroticProtein Interaction MapsLipoproteins, LDL

Stichwörter der Autor:innen

AtherosclerosisBenzo[a]pyreneLipid metabolismMacrophage inflammationSPP1 (osteopontin)

Substanzen

Benzo(a)pyreneOsteopontinSpp1 protein, mouseSPP1 protein, humanInflammation Mediatorsoxidized low density lipoproteinLipoproteins, LDL

Autor:innen und Institutionen

  • Department of Vascular Diseases, Panzhihua Central Hospital, Panzhihua 617000, China.
  • Department of Pharmacy, Cancer Hospital of Shantou University Medical College, China.
  • School of Clinical Medicine, Tsinghua University, Beijing 102218, China.
  • Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YG, UK. Electronic address: s.cai6@lancaster.ac.uk.

Zitieren

APA

Li, R., Zheng, J., Tang, Y., Liu, A., Liu, J., & Cai, S. (2026). Benzo[a]pyrene exacerbates atherosclerosis by upregulating SPP1 to promote macrophage inflammation and lipid dysregulation: An integrated network toxicology, RNA-seq, and experimental validation study. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2026.107589

Vancouver

Li R, Zheng J, Tang Y, Liu A, Liu J, Cai S. Benzo[a]pyrene exacerbates atherosclerosis by upregulating SPP1 to promote macrophage inflammation and lipid dysregulation: An integrated network toxicology, RNA-seq, and experimental validation study. Vascular Pharmacology. 2026. doi:10.1016/j.vph.2026.107589

BibTeX
@article{Li2026,
  author = {Li, Runwen and Zheng, Jieting and Tang, Yongjiang and Liu, Aman and Liu, Jiang and Cai, Shanshan},
  title = {Benzo[a]pyrene exacerbates atherosclerosis by upregulating SPP1 to promote macrophage inflammation and lipid dysregulation: An integrated network toxicology, RNA-seq, and experimental validation study},
  journal = {Vascular Pharmacology},
  year = {2026},
  doi = {10.1016/j.vph.2026.107589}
}
Kostenlos starten →